Sam Altman launches Merge Labs, a brain-computer interface startup that directly challenges Elon Musk's Neuralink. The OpenAI chief executive partners with Alex Blania, creator of the Worldcoin iris-scanning project, to develop this venture. Financial Times reports indicate the company holds an $850 million valuation while seeking $250 million in additional funding. OpenAI's investment arm provides substantial backing for the ambitious project. Altman predicted this human-machine merger would occur by 2025 during a 2017 forecast.
Merge Labs pursues less invasive brain-computer connections compared to Neuralink's surgical implant approach. The startup targets broader applications beyond medical treatments through scalable interface technology. Neuralink maintains competitive advantages with active human trials and a $9 billion market value. Musk's company raised $650 million this year after demonstrating cursor control through brain implants. This rivalry extends the ongoing conflict between the two technology leaders into neurotechnology development.
Merge Labs pursues less invasive brain-computer connections compared to Neuralink's surgical implant approach. The startup targets broader applications beyond medical treatments through scalable interface technology. Neuralink maintains competitive advantages with active human trials and a $9 billion market value. Musk's company raised $650 million this year after demonstrating cursor control through brain implants. This rivalry extends the ongoing conflict between the two technology leaders into neurotechnology development.
